Launched Neurosterix with Perceptive Advisors, raising USD 65 million in Series A to advance preclinical portfolioIndivior selected GABAB PAM drug candidate and started IND enabling studies for develo ...

A conference call will be held today, April 25, 2025, at 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT) to review the ...

Unfortunately, the same cannot be said for Europe. While it has been home to some of the most important biopharmaceutical companies in the world – many of which have consistently delivered ...

Fortrea Holdings Inc.’s FTRE share price has surged by 5.64%, which has investors questioning if this is right time to sell.

FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced the appointment of Renée Aguiar-Lucander as Chief Executive Officer (CEO), effective immediately. Søren ...

Tonix Pharmaceuticals Holding Corp.’s TNXP share price has surged by 7.99%, which has investors questioning if this is right ...

Controversies in the Treatment of Ischemia-Reperfusion Injury, ” will focus on past and current strategies for reducing the myocardial damage caused by IRI following percutaneous coronary intervention ...

The biopharmaceutical industry is positioned for continued recovery, driven by recent FDA approvals and billion-dollar ...

The board of the company has also sanctioned an increase in authorised share capital from ₹625 crore to ₹700 crore.

PHAXIAM Therapeutics (Euronext: PHXM - FR001400K4B1), a biopharmaceutical company ("the Company" or "PHAXIAM") developing innovative treatments for severe and resistant bacterial infections, announces ...

European equities traded in the US as American depositary receipts rose in Thursday morning trading, gaining 0.51% to 1,375.50 on the S&P Europe Select ADR Index. From continental Europe, the gainers ...